Mental Health App for Depression in Cancer Survivors
(MACS Trial)
Trial Summary
Do I have to stop taking my current medications?
The trial excludes people using prescription medicine for depression, so you cannot be on such medications to participate.
What data supports the idea that Mental Health App for Depression in Cancer Survivors is an effective treatment?
The available research shows that app-based interventions can be effective for cancer survivors dealing with depression. For example, a pilot study on a similar app-based stress management program called StressProffen found significant reductions in stress and anxiety, along with improvements in quality of life for participants. This suggests that app-based treatments like the IONA Mind app could also be beneficial for cancer survivors experiencing depression.12345
What safety data exists for the IONA Mind app for depression in cancer survivors?
Is the IONA Mind app a promising treatment for depression in cancer survivors?
Yes, the IONA Mind app is a promising treatment because it can help cancer survivors access mental health support easily through their phones, which is important since many face barriers to in-person care. Mobile apps like this can reach more people and provide support for mental health issues.12467
What is the purpose of this trial?
The goal of this clinical trial is to adapt a mental health digital app to treat depression among head and neck cancer patients and survivors.Participants will download and use the digital mental health app for a 6-week period, and will complete related surveys.
Research Team
Earlise Ward, PhD
Principal Investigator
University of Wisconsin, Madison
Eligibility Criteria
This trial is for adults over the age of 22 who have a history of head and neck cancer (HNC) confirmed by medical records. They must be experiencing moderate to severely moderate depression, with specific scores on a health questionnaire (PHQ-9). Participants need to commit to the study's procedures and timeline.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use the IONA Mind app for mental health support for a 6-week period
Follow-up
Participants are monitored for safety and effectiveness after treatment, with follow-up assessments at 1- and 3-months post-intervention
Treatment Details
Interventions
- IONA Mind app
IONA Mind app is already approved in United Kingdom, United States for the following indications:
- Mental health support for chronic diseases
- Depression among head and neck cancer patients and survivors
- Mental health support for chronic diseases
- Depression among head and neck cancer patients and survivors
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Madison
Lead Sponsor
National Cancer Institute (NCI)
Collaborator